SCHEMBL8560748

SCHEMBL8560748

CCOC(=O)C1SCCNC1=O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
NPC1 O15118 1/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAP2K1 Q02750 6/20 0.45
KDM4E B2RXH2 1/20 0.43
POLB P06746 2/20 0.41
HSD17B10 Q99714 2/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
PKM P14618 1/20 0.38
TSHR P16473 1/20 0.37
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8560743 1.00 ALDH1A1 (0.46) ALDH1A1NPC1LMNATP53RAB9A
SCHEMBL10833113 0.90 KDM4E (0.42) ALDH1A1NPC1LMNATP53RAB9A
SCHEMBL9510438 0.76 KDM4E (0.39) ALDH1A1NPC1KDM4EHSD17B10KMT2A
SCHEMBL7782098 0.73 CYP2D6 (0.38) ALDH1A1NPC1KDM4EHSD17B10KMT2A
SCHEMBL31517932 0.73 CYP2D6 (0.38) ALDH1A1NPC1KDM4EHSD17B10KMT2A
SCHEMBL10833114 0.73 KDM4E (0.44) ALDH1A1NPC1LMNATP53RAB9A
SCHEMBL907623 0.72 MAPT (0.45) ALDH1A1LMNARAB9AKDM4EPOLB
SCHEMBL27405623 0.72 MAPT (0.45) ALDH1A1LMNARAB9AKDM4EPOLB
SCHEMBL10833048 0.72 MAP2K1 (0.45) ALDH1A1NPC1LMNARAB9ASMN1; SMN2
SCHEMBL16931286 0.71 POLB (0.39) ALDH1A1RAB9AKDM4EPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846111-A1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMACEUTICALS, INC. (US) 1998-06-10 EP disclosed
WO-1996040674-A1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMACEUTICALS, INC. (US) 1996-12-19 WO disclosed
US-4578378-A (Oxoheterocyclic carbonamido)cephem carboxylic acid derivatives SHIONOGI & CO., LTD. (JP) 1986-03-25 US disclosed